Prof. Director; Medical Intensive Care Unit
Denver Health
Englewood, CO
Ivor S. Douglas, MD, is Professor of Medicine at the University of Colorado, and Chief of Pulmonary and Critical Medicine at Denver Health Medical Center where he has directed the medical ICU since 2002. Having graduated medical school in South Africa and after Internal Medicine Residency training in London, Great Britain, he completed pulmonary & critical care fellowship training the University of Chicago. Dr. Douglas is principle investigator for ongoing investigations in several aspects of critical care, including basic mechanistic and translational studies in acute lung injury, sepsis and shock resuscitation. Dr. Douglas directs an NIH and industry funded research program exploring sepsis, ARDS and long-term outcomes from critical illness. His work in health critical care leadership and health services include sepsis resuscitation programs using Lean systems engineering techniques. He has authored or co-authored over 130 scientific publications and book chapters. Dr. Douglas has received teaching awards at the U. Chicago, Columbia University, and U. Colorado. Dr. Douglas served as chair of the American Thoracic Society’s Health Policy Committee and the ATS Critical Care Assembly program committee for 2014-16. Dr. Douglas has been recognized annually since 2008 in Denver 5280’s “Top Doc” and “Best Doctors in America” lists. He is Fellow of the Royal College of Physicians (FRCP) and is an avid music listener, player and choral singer.
Saturday, January 21, 2023
1:45 PM – 2:45 PM PT
Disclosure information not submitted.
Sunday, January 22, 2023
11:05 AM – 11:30 AM PT
Disclosure(s): Baxter: Contracted Research (Principal Investigators must provide information, even if received by the institution) (Ongoing), Grant/Research Support (Ongoing), Scientific Advisory Board (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
Monday, January 23, 2023
8:55 AM – 9:55 AM PT
Disclosure information not submitted.
Monday, January 23, 2023
10:20 AM – 10:30 AM PT
Disclosure information not submitted.